CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the company will be participating in the upcoming Raymond James & Associates’ 45th Annual Institutional Investors Conference.

CareDx’s management is scheduled to present on Wednesday, March 6, 2024, at 9:50 a.m. Eastern Standard Time. Interested parties may access a live audio webcast by visiting the “Investors” section of the company’s website at investors.CareDx.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit www.CareDx.com.

CareDx, Inc. Media Relations Anna Czene 818-731-2203 aczene@caredx.com

Investor Relations Greg Chodaczek investor@caredx.com

CareDx (NASDAQ:CDNA)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more CareDx Charts.
CareDx (NASDAQ:CDNA)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more CareDx Charts.